The value versus growth equity story has been one of two halves in the past two decades. This has been the case not only in developed markets – which tend to command the most attention from investors and researchers alike – but also in emerging ones. Emerging markets value stocks performed strongly between 2000 and 2010 before succumbing to the resurgence in growth stocks from 2011 onwards.
During the first wave of Covid-19, global economic growth collapsed while long-term interest rates dropped to extremely low levels. The 10-year US Treasury yields nosedived to an historic low of 0.5% in early August 2020. At that stage, corporate earnings growth had become extremely scarce, and investors flocked to any stock showing minimal signs of growth.
Sectors with a growth angle substantially outperformed the broader market, and in particular more cyclical ones. In emerging markets, Chinese internet stocks were perhaps the most telling example of such an extreme performance gap. Even as global equities markets collapsed, in March 2020, these stocks emerged from the turmoil virtually unscathed, rallying strongly in the recovery that followed.
Vaccine promise triggers a rotation
The progress made on vaccines to fight the pandemic proved to be a turning point for style performance. With the promising results of several vaccine-candidates released in the last quarter of 2020, global economic growth prospects improved, and long-term interest rates rose steeply from depressed levels. For instance, 10-year US Treasury yields rose from 0.5% to 1.7% in the space of just eight months.
At the same time, energy prices and commodity prices generally started to rally as well. As a result, the earnings outlook for companies in the Energy and Materials sectors, as well as in the Financial sector, improved significantly. Corporate earnings growth became less scarce across the board and growth stocks started to underperform their value counterparts.
Jan de Bruijn
Client Portfolio Manager
We believe that further outperformance lies ahead for value, as long as the economic outlook continues to improve
Many investors interpret this simplistically as a rotation from growth to value. But there’s more to it than that, as value comes in different shades. We have witnessed the initial rotation phase from growth into value. This was a classic start to the reflation trade, with investors buying into cheap laggards, resulting in deep value stocks initially outperforming the broader market.
We believe that further outperformance lies ahead for value, as long as the economic outlook continues to improve. However, we expect investors to become increasingly selective in their choice of value stocks. Investors will start to look for stocks that deliver on their perceived value, showing better earnings potential in a normalization of the macroeconomic backdrop.
Therefore, after the first wave of value investing has boosted all cheap stocks, we expect the second wave to focus on what we call ‘value with a future’; in other words, companies with inexpensive valuations that do not discount their sustained earnings growth ahead. Given the polarization we have seen in emerging markets over the course of 2020, there still are attractively valued opportunities to choose from.
Figure 1: MSCI Emerging Markets Value and Growth Indices
Source: MSCI, Robeco, May 2021.
This phenomenon was reflected in the performance of Robeco’s Fundamental Emerging Markets Equity strategies, which have an inherent value tilt, consistent with our investment philosophy. Starting from the second half of 2020, these strategies substantially outperformed the MSCI Emerging Markets Index, gross of fees (see Figure 1).
With the gradual comeback of value stocks, we only made minor adjustments to our positions in emerging markets. We modestly increased our exposure to deeper value by taking profits in selective growth names in China, but also in some IT hardware stocks in Taiwan and South Korea, all of which outperformed strongly in 2020.
With the proceeds, we increased our positions in Financials and Materials, where we believe some attractive value opportunities are to be found. For example, we participated in the IPO of a Brazilian company that has a large market share in iron ore exports to steel-hungry China. After an initial share price return of 22%, the company is still trading at a very low price-to-earnings ratio of six times.
We also increased our positions in the Financials sector in India and Greece, and initiated positions in a South Korean manufacturer of construction equipment. We think this company, which is trading at an attractive valuation, will benefit from the global increase in infrastructure investments over the next couple of years.
当資料は情報提供を目的として、Robeco Institutional Asset Management B.V.が作成した英文資料、もしくはその英文資料をロベコ・ジャパン株式会社が翻訳したものです。資料中の個別の金融商品の売買の勧誘や推奨等を目的とするものではありません。記載された情報は十分信頼できるものであると考えておりますが、その正確性、完全性を保証するものではありません。意見や見通しはあくまで作成日における弊社の判断に基づくものであり、今後予告なしに変更されることがあります。運用状況、市場動向、意見等は、過去の一時点あるいは過去の一定期間についてのものであり、過去の実績は将来の運用成果を保証または示唆するものではありません。また、記載された投資方針・戦略等は全ての投資家の皆様に適合するとは限りません。当資料は法律、税務、会計面での助言の提供を意図するものではありません。 ご契約に際しては、必要に応じ専門家にご相談の上、最終的なご判断はお客様ご自身でなさるようお願い致します。 運用を行う資産の評価額は、組入有価証券等の価格、金融市場の相場や金利等の変動、及び組入有価証券の発行体の財務状況による信用力等の影響を受けて変動します。また、外貨建資産に投資する場合は為替変動の影響も受けます。運用によって生じた損益は、全て投資家の皆様に帰属します。したがって投資元本や一定の運用成果が保証されているものではなく、投資元本を上回る損失を被ることがあります。弊社が行う金融商品取引業に係る手数料または報酬は、締結される契約の種類や契約資産額により異なるため、当資料において記載せず別途ご提示させて頂く場合があります。具体的な手数料または報酬の金額・計算方法につきましては弊社担当者へお問合せください。 当資料及び記載されている情報、商品に関する権利は弊社に帰属します。したがって、弊社の書面による同意なくしてその全部もしくは一部を複製またはその他の方法で配布することはご遠慮ください。 商号等： ロベコ・ジャパン株式会社 金融商品取引業者 関東財務局長（金商）第２７８０号 加入協会： 一般社団法人 日本投資顧問業協会